Corrigendum to 'Efficacy and safety of paclitaxel liposome versus paclitaxel in combination with carboplatin in the first-line chemotherapy for ovarian cancer: a multicenter, open-label, non-inferiority, randomized controlled trial' [Journal of the National Cancer Center 4 (2024) 135-141]
对“紫杉醇脂质体与紫杉醇联合卡铂一线化疗治疗卵巢癌的疗效和安全性：一项多中心、开放标签、非劣效性、随机对照试验”的更正[《国家癌症中心杂志》4 (2024) 135-141]
期刊:Journal of the National Cancer Center
影响因子:9.4
doi:10.1016/j.jncc.2024.11.002
Li, Rong; Zhang, Hongping; Li, Qingshui; Yuan, Guangwen; Zhou, Yanjie; Yin, Rutie; Wang, He; Wang, Chunyan; Huang, Yi; Wang, Wei; Yan, Xiaojian; Wu, Lingying; Zhou, Qi
